Skip to main content
. Author manuscript; available in PMC: 2010 Sep 7.
Published in final edited form as: Neurotoxicology. 2010 May 24;31(5):493–501. doi: 10.1016/j.neuro.2010.05.006

Table 3.

Relationship between GB/GF exposure and factor analysis-derived syndromes

Syndrome Exposed
Unexposed
χ 2 p-value
No affected (%) No affected (%)
1 “impaired cognition” 3/40 (8) 3/40 (8) 0.00 1.00
2 “confusion-ataxia” 5/40 (13) 4/40 (10) 0.12 0.73
3 “arthro-myo-neuropathy” 4/40 (10) 5/40 (13) 0.12 0.73
4 “phobia-apraxia” 5/40 (13) 4/40 (10) 0.12 0.73
5 “fever-adenopathy” 2/40 (5) 2/40 (5) 0.00 1.00
6 “weakness-incontinence” 1/40 (3) 2/40 (5) 0.34 0.56